75 results
8-K
EX-99.1
CUE
Cue Biopharma Inc
9 May 24
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:01pm
earned from our Collaboration and Option Agreement with Ono Pharmaceutical, which was executed in February 2023.
Research and development expenses … and per share amounts)
Three Months Ended
March 31,
Collaboration revenue
Operating expenses:
General and administrative
Research and development
424B3
ov5h0gkwepe 02i
15 Dec 22
Prospectus supplement
4:42pm
8-K
EX-99.1
2j1e1 nsyq7d7q
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
1kixii39w8ouh1u5 i6a
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
txae85dp
30 Mar 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
2gwafjr9me0g
30 Mar 22
Entry into a Material Definitive Agreement
4:10pm